Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Sales (2018 - 2025)

Historic Return on Sales for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 3.43%.

  • Cue Biopharma's Return on Sales fell 8900.0% to 3.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.25%, marking a year-over-year decrease of 6900.0%. This contributed to the annual value of 4.29% for FY2024, which is 47200.0% up from last year.
  • As of Q3 2025, Cue Biopharma's Return on Sales stood at 3.43%, which was down 8900.0% from 2.86% recorded in Q2 2025.
  • Over the past 5 years, Cue Biopharma's Return on Sales peaked at 0.96% during Q4 2021, and registered a low of 508.0% during Q2 2022.
  • Its 5-year average for Return on Sales is 49.47%, with a median of 7.05% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -5042500bps in 2022, then soared by 4986300bps in 2023.
  • Quarter analysis of 5 years shows Cue Biopharma's Return on Sales stood at 0.96% in 2021, then crashed by -9763bps to 94.26% in 2022, then skyrocketed by 92bps to 7.1% in 2023, then grew by 16bps to 5.93% in 2024, then surged by 42bps to 3.43% in 2025.
  • Its Return on Sales stands at 3.43% for Q3 2025, versus 2.86% for Q2 2025 and 28.81% for Q1 2025.